Table 1.
Clinical characteristics and presence of the novel MRI markers
| sCAA (n = 33) | Non-sCAA-ICH (n = 29) | |
|---|---|---|
| Median age in years (range) | 70 (55–83) | 58 (18–84) |
| Women (%) | 13 (39) | 7 (24) |
| Symptomatic ICH (%) | 19 (58) | 29 (100) |
| Lobar (%) | 19 (58) | 0 (0) |
| Deep (%) | 0 | 23 (79) |
| Infratentorial (%) a | 0 | 6 (21) |
| Hypertension (%) | 16 (49) b | 19 (67) |
| Hypercholesterolemia (%) | 9 (27) b | 8 (28) |
| Diabetes mellitus type 2 (%) | 1 (3) b | 0 |
| Novel markers | ||
| Striped occipital cortex on MRI (%) | 1 (3) | 0 |
| Intragyral hemorrhage on MRI (%) | 4 (12) | 0 |
Note: MRI: magnetic resonance imaging; ICH: intracerebral hemorrhage; sCAA: sporadic cerebral amyloid angiopathy.
a
ICH located in the cerebellum or brainstem.
b
n = 32, information was not available for one CAA participant.